These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26471693)

  • 1. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
    J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
    Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with
    Houghton JL; Abdel-Atti D; Scholz WW; Lewis JS
    Mol Pharm; 2017 Mar; 14(3):908-915. PubMed ID: 28191976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
    Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
    Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
    Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
    Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with
    Zhang Y; Lin Q; Wang T; Shi D; Fu Z; Si Z; Xu Z; Cheng Y; Shi H; Cheng D
    Mol Pharm; 2022 Jan; 19(1):246-257. PubMed ID: 34816721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Copper-64-Based Host-Guest Chemistry Pretargeted Positron Emission Tomography.
    Jallinoja VIJ; Carney BD; Bhatt K; Abbriano CH; Schlyer DJ; Yazaki PJ; Houghton JL
    Mol Pharm; 2022 Jul; 19(7):2268-2278. PubMed ID: 35700402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
    Meyer JP; Tully KM; Jackson J; Dilling TR; Reiner T; Lewis JS
    Bioconjug Chem; 2018 Feb; 29(2):538-545. PubMed ID: 29378403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
    Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model.
    Escorcia FE; Steckler JM; Abdel-Atti D; Price EW; Carlin SD; Scholz WW; Lewis JS; Houghton JL
    Mol Imaging Biol; 2018 Oct; 20(5):808-815. PubMed ID: 29508263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of [
    Poulie CBM; Jørgensen JT; Shalgunov V; Kougioumtzoglou G; Jeppesen TE; Kjaer A; Herth MM
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33494416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeted PET of Osteodestructive Lesions in Dogs.
    Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
    Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing
    Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [
    Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ
    Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
    Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
    Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.